Active, not recruitingNot applicableNCT07176338
Role of Metformin in Posterior Capsule Opacification
Studying Metabolic disease with cataract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vienna Institute for Research in Ocular Surgery
- Principal Investigator
- Oliver Findl, Prim. Prof. Dr.Vienna Institute for Research in Ocular Surgery (VIROS)
- Intervention
- Blood and lens capsule samples for PK testing(diagnostic_test)
- Enrollment
- 40 enrolled
- Eligibility
- 21-105 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- Vienna Institute for Research in Ocular Surgery (VIROS), Vienna, Austria
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07176338 on ClinicalTrials.gov